Evonik offers process development and scale-up services for long-acting microparticle and implant products, supporting projects originating from Evonik feasibility studies or from projects transferred from customer programs. Process development activities leverage Evonik’s continuous microencapsulation and hot melt extrusion technologies. Scale-up programs establish robust, reproducible manufacturing processes and generate material for GLP toxicology, stability, and other preclinical studies.
Benefits at a glance
- Experience: 50+ years of process expertise and drug delivery innovation, supporting pharmaceutical development from concept through commercialization.
- Proven: Market-tested microparticle and implant dosage forms with demonstrated clinical and commercial success.
- Innovative: Scalable continuous microencapsulation and hot melt extrusion technologies designed to accelerate development and manufacturing.
- Safe: Biocompatible, bioabsorbable RESOMER® and LACTEL® polymers with well-established safety profiles.
- Trusted: Lactide/glycolide polymer technologies used in more than 60 approved pharmaceutical products worldwide